Filter Results :

Your search for Lymphoma returned 119 reports

Sort by


Global Non-Hodgkin Lymphoma Partnering 2010 to 2016

01 Apr 2016  |  Published by:  CurrentPartnering
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world’s leading healthcare companies. • Trends in partnering deals • Top deals by value • Deals list...

$ 1,495.00

Read More

Global Lymphoma Partnering 2010 to 2016

01 Apr 2016  |  Published by:  CurrentPartnering
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world’s leading healthcare companies. • Trends in partnering deals • Top deals by value • Deals list...

$ 1,495.00

Read More

Small lymphocytic lymphoma- Market Insights, Epidemiology and Market Forecast-2020

01 Apr 2016  |  Published by:  DelveInsight
Note*: This report requires 5-10 business days to complete. Small lymphocytic lymphoma - Market Insights, Epidemiology and Market Forecast-2020” Reports provides an overview of the disease and global market trends of the %Indication% for the seven major markets ie: United States, EU5 (France,...

$ 4,950.00

Read More

Hodgkin's lymphoma (HL)- Market Insights, Epidemiology and Market Forecast-2020

01 Apr 2016  |  Published by:  DelveInsight
Note*: This report requires 5-10 business days to complete. Hodgkin’s lymphoma (HL) - Market Insights, Epidemiology and Market Forecast-2020” Reports provides an overview of the disease and global market trends of the %Indication% for the seven major markets ie: United States, EU5 (France, Ge...

$ 4,950.00

Read More

Mantle Cell Lymphoma - Pipeline Review, H1 2016

29 Feb 2016  |  Published by:  Global Markets Direct
Summary‘Mantle Cell Lymphoma - Pipeline Review, H1 2016’, provides an overview of the Mantle Cell Lymphoma pipeline landscape. The report provides comprehensive information on the therapeutics under development for Mantle Cell Lymphoma, complete with analysis by stage of development,...

$ 2,000.00

Read More

Indolent Lymphoma - Pipeline Review, H1 2016

29 Feb 2016  |  Published by:  Global Markets Direct
Summary‘Indolent Lymphoma - Pipeline Review, H1 2016’, provides an overview of the Indolent Lymphoma pipeline landscape. The report provides comprehensive information on the therapeutics under development for Indolent Lymphoma, complete with analysis by stage of development, drug tar...

$ 2,000.00

Read More

Hodgkin Lymphoma - Pipeline Review, H1 2016

29 Feb 2016  |  Published by:  Global Markets Direct
Summary‘Hodgkin Lymphoma - Pipeline Review, H1 2016’, provides an overview of the Hodgkin Lymphoma pipeline landscape. The report provides comprehensive information on the therapeutics under development for Hodgkin Lymphoma, complete with analysis by stage of development, drug target...

$ 2,000.00

Read More

Non-Hodgkin's Lymphoma (NHL) - Market Insights, Epidemiology and Market Size Forecast-2020

01 Feb 2016  |  Published by:  DelveInsight
DelveInsight’s “Non-Hodgkin’s Lymphoma (NHL) - Market Insights, Epidemiology and Market Size Forecast-2020” Reports provides an overview of the disease and global market size of the Non-Hodgkin’s Lymphoma (NHL) for the United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. It also i...

$ 4,950.00

Read More

Acute Lymphoblastic Lymphoma Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

01 Jan 2016  |  Published by:  DelveInsight
Summary'Acute Lymphoblastic Lymphoma- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014', report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding fo...

$ 2,000.00

Read More

Burkitt Lymphoma Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

01 Jan 2016  |  Published by:  DelveInsight
Summary'Burkitt Lymphoma- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014', report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufa...

$ 2,000.00

Read More

Cutaneous T-Cell Lymphoma Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

01 Jan 2016  |  Published by:  DelveInsight
Summary'Cutaneous T-Cell Lymphoma- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014', report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for A...

$ 2,000.00

Read More

Follicular Lymphoma Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

01 Jan 2016  |  Published by:  DelveInsight
Summary'Follicular Lymphoma- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014', report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Man...

$ 2,000.00

Read More

Lymphoblastic Lymphoma Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

01 Jan 2016  |  Published by:  DelveInsight
Summary'Lymphoblastic Lymphoma- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014', report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API ...

$ 2,000.00

Read More

Mantle Cell Lymphoma Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

01 Jan 2016  |  Published by:  DelveInsight
Summary'Mantle Cell Lymphoma- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014', report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Ma...

$ 2,000.00

Read More

Peripheral T-Cell Lymphomas (PTCL) Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

01 Jan 2016  |  Published by:  DelveInsight
Summary'Peripheral T-Cell Lymphomas (PTCL)- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014', report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understand...

$ 2,000.00

Read More
Total 119 records.